For instance, upregulated tricellulin is correlated with unfavorable clinical outcomes in patients with hepatocellular carcinoma, while downregulated tricellulin in intrahepatic cholangiocarcinoma was linked to a worse prognosis (17). This evidence concerns the gene MARVELD2 and intrahepatic cholangiocarcinoma.